常见问题

截至2023年12月31日，澳门第一赌城在线娱乐拥有约89,900名员工:

• 38%新兴市场
• 35%的欧洲
• 20% US
• 在世界其他地区，这一比例为7%

有关雇员的详情，请参阅最新一期的第33页 年度报告. Further details on the market definitions used can be found on page 232 of the latest 年度报告.

The total number of shares in issue as at 31 December 2023 was 1,550,162,626.

澳门在线赌城娱乐(AstraZeneca PLC)每月公布其投票权总数. 这些通知可以在 证券交易所公告.

澳门在线赌城娱乐在伦敦、斯德哥尔摩和纳斯达克交易所上市. 这三个市场的股票代码都是AZN.

AstraZeneca ad在这里s to the International Financial Reporting Standards (IFRS) and International Accounting Standards (IAS) with appropriate conversion to US GAAP being shown in our financial statements.

请浏览澳门第一赌城在线娱乐的 债券投资者 有关澳门在线赌城娱乐当前债务评级的详细信息.

046353108.

澳门在线赌城娱乐以美元报告.

AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of 瑞典 and Zeneca PLC of the United Kingdom.

这些信息可以在 财务业绩组.

For information on dividends, please see the 股息 section of the 常见问题.

股利政策

在2021年, AstraZeneca announced that from September 2021 the Company would stop making dividend payments by way of cheque. 股息将只以电子方式支付.

取消支票有很多好处. T在这里 is a positive environmental benefit through the reduction in dividend stationary. Shareholders also benefit from increased payment security and faster receipt of funds when payments are made electronically. 除了, the removal of cheque payments reduces administration for both AstraZeneca and shareholders, 同时也降低了成本.

Shareholders will need to provide a bank mandate to receive their dividend payment directly into a bank or building society account. 

Holders of Ordinary Shares should contact Equiniti on +44 371 384 2030 (International), 0371 384 2030 (UK) or through the online enquiry form on the Equiniti website. 

ADR持有人应联系Equiniti信托公司, LLC on (888) 697 8018 (toll-free if calling within the US) or +1 718 921 8137 (International) or by email at adr@equiniti.com

Holders of shares traded on Stockholm Nasdaq should contact Euroclear on +46 (0) 8 402 9000. 

At present AstraZeneca does not have a dividend re-investment plan for Ordinary shareholders. Registered American Depositary Receipt holders may elect to have dividends reinvested via the DB Global Direct program. Please contact Equiniti Trust Company, LLC for further details on +1 888 697 8018.

请浏览澳门第一赌城在线娱乐的 股利政策.

AstraZeneca pays the dividend in the currency corresponding to w在这里 the shares are listed.

Holders of Ordinary Shares listed in London may be able to use Equiniti’s Overseas Payment Service to receive the dividend in a currency other than GBP. Holders of Ordinary Shares should contact Equiniti on +44 371 384 2030 (International), 0371 384 2030 (UK) or through the online enquiry form on the Equiniti website.

这将取决于你的股份在哪里持有:

If your shares are held by a broker or nominee please contact them directly.

如你是注册股东，请联络以下人员:

Holders of Ordinary Shares should contact Equiniti on +44 371 384 2030 (International), 0371 384 2030 (UK) or through the online enquiry form on the Equiniti website.

ADR持有人应联系Equiniti信托公司, LLC on (888) 697 8018 (toll-free if calling within the US) or +1 718 921 8137 (International) or by email at adr@equiniti.com

Holders of shares traded on Stockholm Nasdaq should contact Euroclear on +46 (0) 8 402 9000. 

Please follow the link below to a summary of dividends paid in the form of Syngenta shares.

视图 英国成本基础信息 (在新窗口中打开).

Please follow the link below to a summary of dividends paid in the form of Syngenta shares.

视图 美国成本基础信息 (在新窗口中打开).

查看致 阿斯特拉公司股东 (在新窗口中打开).

A legal representative, Peter Haglund, has been appointed to act on behalf of minority shareholders. 可以通过Advokatfirman Sodermark与他联系, 14055箱, SE 104 40斯德哥尔摩, 瑞典, 电话+46 8 670 57 50，传真+46 8 663 67 20.

On 6 April 1999 (the first trading day of AstraZeneca PLC) the closing price was GBP 29.46.

Shares in Zeneca Group PLC acquired on demerger from ICI will be treated as having a base cost for capital gains tax purposes ascertained by reference to the values of Zeneca and ICI shares on 1 June 1993 calculated in accordance with the provisions of Section 272 of the Taxation of Chargeable Gains Act 1992. The base cost of any holding of ICI Shares on that date will be adjusted on the same basis.

1993年6月1日伦敦证券交易所的有关价格如下:

捷利康- 625.75p和ICI - 631.75p

The base cost of the pre-merger ICI Shares were t在这里fore split between the post-demerger Zeneca and ICI Shares in the following proportions:

捷利康- 0.49761和ICI - 0.50239

Astra AB和Zeneca Group PLC的股份于1999年4月6日合并.
1 Astra共享:0.5045澳门在线赌城娱乐股份
1股利康:1股澳门在线赌城娱乐

澳门在线赌城娱乐于2000年11月13日分拆了其农用化学品业务.

在美国, AstraZeneca’s Ordinary Shares are traded in the form of American Depositary Shares (股美国存托凭证), 以美国存托凭证(adr)为证, 在纳斯达克交易的股票代码是AZN. An ADS is a US dollar denominated form of equity ownership representing AstraZeneca’s underlying Ordinary Shares on deposit in the United Kingdom, and it confers the rights arising out of the underlying Ordinary Share including the right to vote at and attend general meetings of AstraZeneca and the right to receive dividends in US dollars.

Historically one ADS has been equal to one Ordinary Share of AstraZeneca, a 1:1 ratio.

2015年7月27日, a ratio change was effected so that two 股美国存托凭证 became equal to one Ordinary Share, 比例为2:1. ADS holders on the record date at the close of business on 22 July 2015 New York time received a distribution of one additional ADS for every one ADS held. 您不需要执行任何操作来实现此更改. These changes brought the AstraZeneca ADS price broadly in line with the market average and, 随着美国存托凭证价格下降, it is thought that  the shares should be more attractive to individual shareholders and liquidity improved.

The number of 股美国存托凭证 that were registered in your name at the close of business on 22 July 2015 New York time were doubled. While it is not possible to isolate the effect of 比率变化 on the price of AstraZeneca’s 股美国存托凭证 from all the factors that affect the price, it is believed that the immediate effect was a reduction in price to approximately one-half of that prevailing immediately before 比率变化. 价格的降低, when coupled with the doubling of the 股美国存托凭证 held in your name should leave the value of your holding approximately the same immediately after, 就像刚才一样, 比率变化.

Following the ADS ratio change in July 2015, each ADS represents half an underlying Ordinary Share. Each ADS held on the dividend record date will  t在这里fore receive half of the dividend rate declared per Ordinary Share. 

No. The ratio change should have no US federal income tax implications for ADS holders, except that such holders should allocate to each additional ADS half of the holder’s tax basis in the original ADS with respect to which the additional ADS was received. 如果你持有美国存托凭证作为美国联邦所得税的资本资产, your holding period for an additional ADS for capital gains tax purposes should include your holding period for the existing ADS with respect to which the additional ADS is received.

是的, 自2015年3月23日支付的第二次中期股息开始, holders of American Depositary Shares (股美国存托凭证) will be charged a total of $0.03 (3 cents) per ADS annually to cover costs related to the ADS programme. 费用为0美元.01 (1 cent) will be deducted from the first interim dividend which is typically announced with second quarter and half year results and paid in September each year, 费用是0美元.02 (2 cents) will be deducted from the second interim dividend which is typically announced with fourth quarter and full year results and paid in March each year. 

A large majority of dividend-paying FTSE100 companies that have an ADR/ADS programme charge dividend fees. AstraZeneca's dividend fee as a percentage of its dividends declared in respect of 2022 ($1.45 / ADR)为2.而富时100指数(FTSE100)赞助的ADR平均水平为6%.5%

A ‘Boiler Room’ fraud may take different forms but typically involves the use of high-pressure sales techniques and the promise of opportunities that appear too good to be true. AstraZeneca shareholders may be targeted by unsolicited phone calls or correspondence from ‘brokers’ who are often based overseas concerning investments and promising high financial returns. 不幸的是, the high profits promised never materialise and shareholders are often left significantly out of pocket. The ‘brokers’ are often both persistent and extremely persuasive with even experienced investors falling victim to the scams.  This type of fraud is called ‘boiler room’ fraud because of the high pressure sales techniques used by the ‘brokers’.  5,000 people contact the Financial Conduct Authority (the ‘FCA’) each year regarding share fraud with victims losing an average of £20,000.

AstraZeneca shareholders are advised to be extremely cautious of any unsolicited approaches offering advice, free reports and offers to buy shares at a discount or sell at an inflated price.

In the event that you receive unsolicited contact regarding an investment opportunity the FCA offers the following advice, 详情可浏览其网页:

• 拒绝任何推销电话
• Take the name of the person that has contacted you along with the full name and address of the organisation which they purport to work for
• 检查该公司是否正确授权，通过Search FCA注册. The FCA strongly advise that individuals should only deal with financial services firms that are properly authorised by the FCA. You should verify the call using the contact details provided on the FCA注册
• If you deal with an unauthorised firm you will not be eligible to receive payment under the Financial Services Compensation Scheme or have access to the Financial Ombudsman Service
• 检查公司是否出现在 FCA警告列表
• Seek impartial advice from a financial adviser before you make an investment
• If a firm does not appear on the FCA注册 or you are told by the ‘broker’ that the details are out of date contact the FCA on 0800 111 6768 or use the FCA reporting form which can be found 在这里

If you believe that you have already paid money to share fraudsters you should contact ActionFraud on +44(0)300 123 2040.

我在哪里可以找到更多的信息?

有关锅炉房及股票诈骗的更多资料，请浏览 FCA网站 在 ActionFraud网站.

有关锅炉房及股票诈骗的更多资料，请浏览 FCA网站 在 行动诈骗网站.